COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 188

Article download: 86

IP International Journal of Ocular Oncology and Oculoplasty


Glaucoma after penetrating keratoplasty: Risk factors and its management


Full Text PDF Share on Facebook Share on Twitter


Review Article

Author Details : Anuradha Raj*, Harsh Bahadur

Volume : 5, Issue : 2, Year : 2019

Article Page : 44-48


Suggest article by email

Abstract

Glaucoma is the second leading cause of graft failure after penetrating keratoplasty. Prompt diagnosis and aggressive management is mandatory to salvage the graft. Indications of penetrating keratoplasty, lens status, additional procedures with penetrating keratoplasty, preexisting glaucoma and re-graft are the main risk factors for glaucoma after penetrating keratoplasty. Various newer modalities like recent tonopens, ultrasound biomicroscopy, and anterior segment optic coherence tomography are helpful tools for its diagnosis. Various newer drugs, surgical modifications such as trabeculectomy with antimetabolites like mitomycin-C and 5 fluorouracil, glaucoma drainage devices, cyclodestructive procedures have added the chances of success of its management, but still graft failure secondary to glaucoma is very common.

Keywords: Trabeculectomy, Glaucoma drainage device, Graft failure.

Doi : 10.18231/j.ijooo.2019.012

How to cite : Raj A, Bahadur H, Glaucoma after penetrating keratoplasty: Risk factors and its management. IP Int J Ocul Oncol Oculoplasty 2019;5(2):44-48

Copyright © 2019 by author(s) and IP Int J Ocul Oncol Oculoplasty. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)